首页> 美国卫生研究院文献>Avicenna Journal of Medical Biotechnology >Can Aptameric Ligands Specific to Plasma Coagulation Factor VII Bind the Recombinant Form with High Affinity: Affinity Measurement by Fluorescence Method
【2h】

Can Aptameric Ligands Specific to Plasma Coagulation Factor VII Bind the Recombinant Form with High Affinity: Affinity Measurement by Fluorescence Method

机译:可以对血浆凝血因子VII进行特异性的配体配体以高亲和力结合重组形式:通过荧光法进行亲和力测量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Among diverse protein purification systems, affinity chromatography is the most attractive one in the purification process of coagulation factors. Coagulation factor VII is a plasma serine protease that has a significant role in natural human hemostasis and its recombinant form such as AryoSeven, has been applied in clinical treatment of bleeding disorders. Immunoaffinity chromatography is the purification method of choice that is currently applied in the development of coagulation factor VIIa products. Aptamers as nucleic acid based affinity ligands are more promising than monoclonal antibodies. In addition, DNA aptamers are more acceptable than RNA ones in this regard.
机译:背景:在多种蛋白质纯化系统中,亲和色谱法是凝血因子纯化过程中最吸引人的方法。凝血因子VII是一种血浆丝氨酸蛋白酶,在天然人类止血中具有重要作用,其重组形式如AryoSeven 已用于临床治疗出血性疾病。免疫亲和色谱法是目前选择用于纯化凝血因子VIIa产品的纯化方法。作为基于核酸的亲和配体的适体比单克隆抗体更有希望。另外,在这方面,DNA适体比RNA更容易接受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号